InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Sitar Edward J, Chief Financial Officer. Officer active across 2 companies, notably 9 METERS BIOPHARMA, INC.. Cumulatively, 5 reports have been recorded. Total volume traded: €43k. The latest transaction was filed on 15 April 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
0150,000 shares0
Common Stock, par value $0.001 per share
SEC:0001104659-22-047216:0·
€6,13815,000 shares@ €0.4092100.0% of flow
Common Stock, par value $0.001 per share
SEC:0000905718-21-001533·
Ideal exit: 20 Aug 2022 (T+270)
€6,13815,000 shares@ €0.409250.0% of flow
Common Stock, par value $0.001 per share
SEC:0000905718-21-001533:0·
Ideal exit: 20 Aug 2022 (T+270)
€15,50215,000 shares@ €1.0335100.0% of flow
Common stock
SEC:0001551986-21-000103·
Ideal exit: 11 Jun 2022 (T+270)
€15,50215,000 shares@ €1.033550.0% of flow
Common stock
SEC:0001551986-21-000103:0·
Ideal exit: 11 Jun 2022 (T+270)
5 of 5 declarations
About Sitar Edward J
Edward J. Sitar is the Chief Financial Officer and Board Member at 9 Meters Biopharma, Inc. and Timber Pharmaceuticals, Inc. He is responsible for financial management and the financial strategy of these companies. His role includes overseeing accounting operations and managing financial risks. Through his expertise, he contributes to informed decision-making and the sustainable growth of the companies.
